China Molybdenum Co., Ltd.

SSE:603993.SS

7.06 (CNY) • At close April 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 213,028.665186,268.972172,990.857173,862.586112,981.01968,676.56525,962.86324,147.5586,949.5714,196.846,662.3825,536.4695,710.8946,099.6524,496.9673,132.8095,563.7465,898.9733,826.221
Cost of Revenue 177,961.758168,437.03156,926.248157,539.542104,536.00765,605.69216,180.24715,211.9414,623.8182,622.4483,871.433,733.4684,009.2173,911.372,643.7022,112.2372,409.3471,878.6561,218.789
Gross Profit 35,066.90717,831.94216,064.60916,323.0448,445.0123,070.8739,782.6168,935.6172,325.7531,574.3912,790.9521,803.0011,701.6772,188.2811,853.2641,020.5723,154.3994,020.3172,607.432
Gross Profit Ratio 0.1650.0960.0930.0940.0750.0450.3770.370.3350.3750.4190.3260.2980.3590.4120.3260.5670.6820.681
Reseach & Development Expenses 353.974327.085388.61272.385173.583268.321254.356101.794109.00180.229126.554103.273112.687000000
General & Administrative Expenses 751.844833.17663.31517.215516.019536.028463.575595.34447.195106.575124.754158.674141.826460.023334.99282.744260.205172.0820
Selling & Marketing Expenses 22.31125.05397.17189.7573.45790.65896.822214.84190.61984.67399.81826.9125.3324.62615.10513.99225.0221.3440
SG&A 774.155858.222760.481606.965589.475626.686560.397810.181537.814191.247224.571185.583167.156484.649350.095296.736285.225193.426116.054
Other Expenses 8,672.7433,358.6572,277.2622,236.6581,668.3271,493.09160.185-419.565445.013-2.32860.925243.33751.0159.7630.83614.232-4.931-20.95532.55
Operating Expenses 9,800.8724,682.8213,426.3533,116.0082,431.3852,388.0972,290.7661,704.4041,035.664684.32898.151983.796727.552703.445539.358472.396692.074565.47185.696
Operating Income 25,266.03413,287.97813,732.80214,395.4414,842.4774,307.4997,057.9845,377.079751.169727.2672,138.191,009.9611,046.9791,517.5111,414.578708.8152,520.9673,430.2992,421.736
Operating Income Ratio 0.1190.0710.0790.0830.0430.0630.2720.2230.1080.1730.3210.1820.1830.2490.3150.2260.4530.5820.633
Total Other Income Expenses Net -141.997-80.015-3,928.335-33.36-1,954.451-1,949.05-68.1264.738433.202-44.4489.87226.22149.978-5.5940.123-2.19-30.759-34.94132.55
Income Before Tax 25,124.03713,207.9639,804.4678,755.3142,876.292,358.4486,989.8575,381.8171,190.141682.8182,148.061,236.1821,096.9571,511.9171,414.701707.7862,504.9993,395.3582,454.286
Income Before Tax Ratio 0.1180.0710.0570.050.0250.0340.2690.2230.1710.1630.3220.2230.1920.2480.3150.2260.450.5760.641
Income Tax Expense 9,664.5954,677.3412,612.7663,327.701397.649592.61,839.8161,786.201170.903-20.29347.858151.27180.581355.755357.866181.396656.187983.906739.821
Net Income 13,532.0358,249.7126,066.9475,106.0172,328.7881,857.0144,635.5842,727.796998.041761.161,824.2551,174.2041,050.3051,118.1761,020.692495.0951,640.9012,145.3641,714.465
Net Income Ratio 0.0640.0440.0350.0290.0210.0270.1790.1130.1440.1810.2740.2120.1840.1830.2270.1580.2950.3640.448
EPS 0.630.380.280.240.110.0860.210.140.060.050.120.0770.070.0770.070.0330.10.160.14
EPS Diluted 0.630.380.280.240.110.0860.210.140.060.050.120.0770.070.0770.070.0330.10.160.14
EBITDA 35,269.54520,128.93616,547.01214,895.0689,171.6948,079.71312,811.14411,410.2383,014.9931,922.893,225.3931,678.7311,484.1651,942.0521,672.1581,008.632,628.6373,648.5692,497.429
EBITDA Ratio 0.1660.1080.0960.0860.0810.1180.4930.4730.4340.4580.4840.3030.260.3180.3720.3220.4720.6190.653